Join
Live feed
·
NEWSReleasevia Quantisnow
DMK Pharmaceuticals Corporation logo

DMK Pharmaceuticals shares are trading higher after the company announced it regained full rights to commercialize ZIMHI.

ByQuantisnow·Wall Street's wire, on your screen.
DMK· DMK Pharmaceuticals Corporation
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track DMK (DMK Pharmaceuticals Corporation) and more on Quantisnow.